sofidexFor patientsAre you a clinician? Clinical site
Ask Sofi
Listen
Patient SupportEmergencies & Reporting
Log inSign up

Meds & supplements  ›  Dexrazoxane

Medicine

Dexrazoxane

Dexrazoxane for injection is indicated for reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin dose of 300 mg/m…

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
  • Do not use with the initiation of doxorubicin therapy.
  • Dexrazoxane for injection is a cytoprotective agent indicated for reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin dose of 300 mg/m 2 and who will continue to receive doxorubicin therapy to maintain tumor control.
  • Do not use dexrazoxane for injection with doxorubicin initiation.
Do not take if
Do not use Dexrazoxane for Injection with non-anthracycline chemotherapy regimens.

What it is used for

Dexrazoxane for Injection is indicated for reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin dose of 300 mg/m 2 and who will continue to receive doxorubicin therapy to maintain tumor control. Do not use with the initiation of doxorubicin therapy.

Who should not take it

Do not use Dexrazoxane for Injection with non-anthracycline chemotherapy regimens.

Other medicines and interactions

No drug interactions have been identified.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Dexrazoxane; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/dexrazoxane

APA 7th

sofidex. (2026, August 2). Dexrazoxane. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/dexrazoxane

AMA 11th

Dexrazoxane. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/dexrazoxane

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.